We have located links that may give you full text access.
Transaortic closure of ventricular septal defect in patients with corrected transposition with pulmonary stenosis or atresia.
Circulation 1987 September
In 12 patients having corrected transposition with pulmonary stenosis (n = 8) or atresia (n = 4), the associated ventricular septal defect was repaired transaortically. Ages ranged from 4 to 50 years (mean 14.3). The hemoglobin ranged from 13.2 to 22.4 g/dl (mean 16.6), the hematocrit ranged from 40.2% to 68.2% (mean 49.0%), and the arterial oxygen saturation ranged from 63% to 97% (mean 83.8%). Associated anomalies included atrial septal defect (n = 11), double-outlet right ventricle (n = 7), dextrocardia (n = 4), and mesocardia (n = 2). Ten patients received an extracardiac conduit. There were two in-hospital deaths from low cardiac output. None of the 10 survivors had complete heart block, residual ventricular septal defect, aortic incompetence, or coronary arterial injury. Transaortic closure of ventricular septal defect is preferred in corrected transposition because it minimizes complete heart block (the conduction system courses subendocardially in the pulmonary ventricle), allows secure placement of the patch (on the high-pressure side of the defect), and limits coronary arterial and anterior papillary muscle injury (the pulmonary ventriculotomy for conduit anastomosis may be made in an apical location).
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app